X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (4) 4
humans (4) 4
aged (3) 3
carcinoma, non-small-cell lung - drug therapy (3) 3
male (3) 3
middle aged (3) 3
administration, oral (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
carcinoma, non-small-cell lung - genetics (2) 2
care and treatment (2) 2
chemotherapy (2) 2
disease-free survival (2) 2
erlotinib (2) 2
gefitinib (2) 2
index medicus (2) 2
lung cancer, non-small cell (2) 2
lung neoplasms - drug therapy (2) 2
lung neoplasms - genetics (2) 2
lung neoplasms - pathology (2) 2
mutation (2) 2
oncology (2) 2
survival (2) 2
time factors (2) 2
treatment outcome (2) 2
1st-line therapy (1) 1
4-butyrolactone - analogs & derivatives (1) 1
4-butyrolactone - pharmacology (1) 1
adjuvants (1) 1
agriculture (1) 1
anemia (1) 1
anti-cancer drug (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic agents, phytogenic - administration & dosage (1) 1
antineoplastic agents, phytogenic - adverse effects (1) 1
antitumor-activity (1) 1
apoptosis (1) 1
apoptosis - drug effects (1) 1
bevacizumab - administration & dosage (1) 1
brain edema - diagnosis (1) 1
brain edema - prevention & control (1) 1
brain metastasis (1) 1
brain neoplasms - diagnostic imaging (1) 1
brain neoplasms - drug therapy (1) 1
brain neoplasms - secondary (1) 1
breast cancer (1) 1
breast neoplasms - drug therapy (1) 1
breast neoplasms - metabolism (1) 1
breast neoplasms - pathology (1) 1
c75 (1) 1
cancer (1) 1
cancer patients (1) 1
carboplatin (1) 1
carboplatin - administration & dosage (1) 1
carboplatin/paclitaxel (1) 1
carcinoma (1) 1
carcinoma, non-small-cell lung - diagnostic imaging (1) 1
carcinoma, non-small-cell lung - enzymology (1) 1
carcinoma, non-small-cell lung - mortality (1) 1
carcinoma, non-small-cell lung - pathology (1) 1
carcinoma, non-small-cell lung - secondary (1) 1
carnitine o-palmitoyltransferase - metabolism (1) 1
catechin - analogs & derivatives (1) 1
catechin - pharmacology (1) 1
chi-square distribution (1) 1
cisplatin (1) 1
cisplatin - administration & dosage (1) 1
clinical trials (1) 1
compassionate use trials (1) 1
critical care medicine (1) 1
cytotoxicity (1) 1
data processing (1) 1
deoxycytidine - administration & dosage (1) 1
deoxycytidine - analogs & derivatives (1) 1
development and progression (1) 1
dietary supplements - adverse effects (1) 1
dosage and administration (1) 1
drug administration schedule (1) 1
drugs (1) 1
egcg (1) 1
enzyme inhibitors - pharmacology (1) 1
epidermal growth factor receptors (1) 1
erbb receptors - genetics (1) 1
erlotinib hydrochloride (1) 1
erlotinib hydrochloride - administration & dosage (1) 1
europe (1) 1
eurtac trial (1) 1
exanthema (1) 1
exons (1) 1
fatty acid inhibitors (1) 1
fatty acid metabolism (1) 1
fatty acid synthases - antagonists & inhibitors (1) 1
fatty acids (1) 1
fatty acids - metabolism (1) 1
gemcitabine (1) 1
gene deletion (1) 1
gene mutations (1) 1
genetic aspects (1) 1
green tea (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Rosell, Rafael, Dr and Carcereny, Enric, MD and Gervais, Radj, MD and Vergnenegre, Alain, Prof and Massuti, Bartomeu, MD and Felip, Enriqueta, MD and Palmero, Ramon, MD and Garcia-Gomez, Ramon, MD and Pallares, Cinta, MD and Sanchez, Jose Miguel, MD and Porta, Rut, MD and Cobo, Manuel, MD and Garrido, Pilar, MD and Longo, Flavia, MD and Moran, Teresa, MD and Insa, Amelia, MD and De Marinis, Filippo, MD and Corre, Romain, MD and Bover, Isabel, MD and Illiano, Alfonso, MD and Dansin, Eric, MD and de Castro, Javier, MD and Milella, Michele, MD and Reguart, Noemi, MD and Altavilla, Giuseppe, MD and Jimenez, Ulpiano, MD and Provencio, Mariano, MD and Moreno, Miguel Angel, MD and Terrasa, Josefa, MD and Muñoz-Langa, Jose, MD and Valdivia, Javier, MD and Isla, Dolores, MD and Domine, Manuel, MD and Molinier, Olivier, MD and Mazieres, Julien, Prof and Baize, Nathalie, MD and Garcia-Campelo, Rosario, MD and Robinet, Gilles, MD and Rodriguez-Abreu, Delvys, MD and Lopez-Vivanco, Guillermo, MD and Gebbia, Vittorio, MD and Ferrera-Delgado, Lioba, MD and Bombaron, Pierre, MD and Bernabe, Reyes, MD and Bearz, Alessandra, MD and Artal, Angel, MD and Cortesi, Enrico, MD and Rolfo, Christian, MD and Sanchez-Ronco, Maria, PhD and Drozdowskyj, Ana, PhD and Queralt, Cristina, PhD and de Aguirre, Itziar, PhD and Ramirez, Jose Luis, PhD and Sanchez, Jose Javier, Prof and Molina, Miguel Angel, PhD and Taron, Miquel, PhD and Paz-Ares, Luis, MD and Assoc Italiana Oncologia Toracica and Grp Francais Pneumocancerologie and Spanish Lung Cancer Group in collaboration with Groupe Français de Pneumo-Cancérologie and Associazione Italiana Oncologia Toracica
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 3, pp. 239 - 246
Summary Background Erlotinib has been shown to improve progression-free survival compared with chemotherapy when given as first-line treatment for Asian... 
Hematology, Oncology and Palliative Medicine | IPASS | GEFITINIB | THERAPY | ONCOLOGY | SENSITIVITY | CARBOPLATIN/PACLITAXEL | TUMORS | Erlotinib Hydrochloride | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Prospective Studies | Exons | Lung Neoplasms - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Protein Kinase Inhibitors - adverse effects | Molecular Targeted Therapy | Cisplatin - administration & dosage | Patient Selection | Time Factors | Female | Quinazolines - administration & dosage | Precision Medicine | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Lung Neoplasms - enzymology | Drug Administration Schedule | Administration, Oral | Carcinoma, Non-Small-Cell Lung - genetics | Deoxycytidine - administration & dosage | Europe | Kaplan-Meier Estimate | Proportional Hazards Models | Carboplatin - administration & dosage | Treatment Outcome | Chi-Square Distribution | Carcinoma, Non-Small-Cell Lung - mortality | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Taxoids - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Quinazolines - therapeutic use | Quinazolines - adverse effects | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - enzymology | Mutation | Deoxycytidine - analogs & derivatives | Antimitotic agents | Care and treatment | Chemotherapy | Erlotinib | Lung cancer | Product development | Agriculture | Lung cancer, Non-small cell | Antineoplastic agents | Standards | Cancer
Journal Article
Lancet Respiratory Medicine, The, ISSN 2213-2600, 2017, Volume 5, Issue 5, pp. 435 - 444
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.